echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Micro-Invasive Medical Heart Rhythm Management was invested $105 million in the introduction of High Erity Capital.

    Micro-Invasive Medical Heart Rhythm Management was invested $105 million in the introduction of High Erity Capital.

    • Last Update: 2020-07-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the evening of July 5, Minimally Invasive Medical (0853HK) announced that a number of Member Companies of the Group have entered into agreements to introduce new external investor sorgas to their subsidiary MicroPort CardiaC Rhythm Management Limited (hereinafter referred to as MicroPort CRM) through a targeted issue of new sharesMicro-Health said in a statement that the move was intended to provide additional funding for the development of microPort CRM, a target company, and to take advantage of the growth opportunities of MicroPort CRMMicroPort CRM was established in August 2019In 2018, Minimalco Medical will buy LivaNova, a British medical device company, for $190 millionIn April, Micro-Invention Healthcare injected the acquisition into MicroPort CRMannouncement, new investor SPR-VI Holdings Limited is owned by Hillhouse Fund IV, L.PGaogao Capital is the sole management company of Hillhouse Fund IV, L.PThe total amount of this subscription is $105 millionThe proportion of the subscription amount of gaoying capital accounted for nearly half, reaching 50 million U.Sdollarsit is understood that after the completion of the rights issue agreement, MicroPort CRM's share capital will increase, the proportion of micro-invasive healthcare will be reduced to 52.7 percent, The equity share of Yunfeng Fund will increase to 19.11 percent, and GaoYu Capital's equity ratio will rise to 12.46 percent.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.